Defective histone acetylation is responsible for the diminished expression of cyclooxygenase 2 in idiopathic pulmonary fibrosis.
about
Feedback amplification of fibrosis through matrix stiffening and COX-2 suppressionRecent advances in understanding idiopathic pulmonary fibrosisEpigenomics of idiopathic pulmonary fibrosisPersonalized medicine: applying 'omics' to lung fibrosisFibroblasts in fibrosis: novel roles and mediatorsBeyond the genome: epigenetic mechanisms in lung remodelingEvolving genomic approaches to idiopathic pulmonary fibrosis: moving beyond genesImpaired E Prostanoid2 Expression and Resistance to Prostaglandin E2 in Nasal Polyp Fibroblasts from Subjects with Aspirin-Exacerbated Respiratory Disease.Signal transduction pathways (MAPKs, NF-κB, and C/EBP) regulating COX-2 expression in nasal fibroblasts from asthma patients with aspirin intolerance.Precision Medicine: The New Frontier in Idiopathic Pulmonary FibrosisHypermethylation of PTGER2 confers prostaglandin E2 resistance in fibrotic fibroblasts from humans and mice.Histone deacetylase: a potential therapeutic target for fibrotic disordersCombined pulmonary fibrosis and emphysema.Epigenetics: A New Bridge between Nutrition and Health.Increased constitutive αSMA and Smad2/3 expression in idiopathic pulmonary fibrosis myofibroblasts is KCa3.1-dependent.Lung myofibroblasts are characterized by down-regulated cyclooxygenase-2 and its main metabolite, prostaglandin E2.Epigenetic control of gene expression in the lung.Relationship of DNA methylation and gene expression in idiopathic pulmonary fibrosis.Smoking and pulmonary fibrosis: novel insights.Prostaglandin E2 and the pathogenesis of pulmonary fibrosis.Human lung myofibroblast TGFβ1-dependent Smad2/3 signalling is Ca(2+)-dependent and regulated by KCa3.1 K(+) channelsAirway remodeling in murine asthma correlates with a defect in PGE2 synthesis by lung fibroblasts.Normal Human Lung Epithelial Cells Inhibit Transforming Growth Factor-β Induced Myofibroblast Differentiation via Prostaglandin E2Smoking and idiopathic pulmonary fibrosisCyclooxygenase-2 and microRNA-155 expression are elevated in asthmatic airway smooth muscle cells.Hypoxia-Induced Changes in DNA Methylation Alter RASAL1 and TGFβ1 Expression in Human Trabecular Meshwork Cells.Epigenetics in lung fibrosis: from pathobiology to treatment perspective.Evaluation of epigenetic modulation of cyclooxygenase-2 as a prognostic marker for hepatocellular carcinomaEpigenetic modifying enzyme expression in asthmatic airway epithelial cells and fibroblastsThe role of cyclooxygenase-2 in mechanical ventilation-induced lung injury.Epigenetic regulation of cyclooxygenase-2 by methylation of c8orf4 in pulmonary fibrosisMatrices of physiologic stiffness potently inactivate idiopathic pulmonary fibrosis fibroblasts.Spiruchostatin A inhibits proliferation and differentiation of fibroblasts from patients with pulmonary fibrosis.Histone modifications are responsible for decreased Fas expression and apoptosis resistance in fibrotic lung fibroblasts.Protein kinase D mediates synergistic expression of COX-2 induced by TNF-{alpha} and bradykinin in human colonic myofibroblasts.IDIOPATHIC PULMONARY FIBROSIS IS A COMPLEX GENETIC DISORDER.Endometriosis is characterized by a distinct pattern of histone 3 and histone 4 lysine modifications.Epigenetic Regulation of Interleukin 6 by Histone Acetylation in Macrophages and Its Role in Paraquat-Induced Pulmonary Fibrosis.Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities.Update in diffuse parenchymal lung disease 2009.
P2860
Q24627446-4DF75217-6375-41D6-8651-0F8A26783356Q26745905-3F587285-FFB5-46C1-B070-96F0574F5AC5Q26853673-0B9FC8ED-A813-42F6-A061-9C18AF45AC74Q26866919-D04919BC-4490-4550-8C09-F27C6A7E8CD5Q26998508-862A0FE8-6629-44B3-993F-00AA2F188060Q27021767-3105C343-8D15-44AC-B896-3A7FD546338CQ27025625-E0E9CC55-BC57-41D9-8038-F11260EEE9AEQ30279219-43F30144-E7DD-4C06-B94D-360C555356ABQ30459926-E9BB030F-134B-4CA9-B6CA-81E2E083C9EAQ33714064-8595921B-A711-484F-AE11-39008D676D85Q34254378-6FA17111-B9B7-444B-849D-54522A07AC5BQ34257607-548BF8EF-E961-4249-9C69-2E88A74578AAQ34325239-D9A0B711-EF0A-486F-A609-5C05F44D0B5BQ34591910-42F6CFF1-FEB1-4DB3-A2D6-56A5EAB233BFQ34677065-3E59E51C-0A67-4D5F-A2FF-D9F99628761DQ34766530-10B3EB14-25C3-41ED-85D4-56A8D3EF4D72Q35042509-AE2A1546-D12E-4B28-90A4-E0A12F093F98Q35044740-58C516EA-CE7C-4DD3-9CDA-5C06C987D808Q35101727-06624BF8-2CAE-495B-B9F9-FF5BF524E881Q35219865-DAF23A33-6291-4177-9DB4-07266F8E33BEQ35232951-05878432-6A98-4268-B3D2-90941EDB9D36Q35543575-EA5D7E07-BBBA-4DEF-B12E-BD1E229D4959Q35738996-A7CC780C-2DF0-4D08-A4D3-58100D4EF799Q35788811-17258614-F021-4043-8510-67B62BF510A8Q35816361-53DF90D6-B093-48B8-8C80-816C1CBAC72AQ36001832-DACD3B28-DCE6-43CC-B2E8-9EF4D7162810Q36119163-B0356735-5E14-490E-B737-C6B73FA1FAA7Q36143166-FB623F0C-C6D1-423B-AB8D-F8039B39A900Q36264207-1DA82CE1-6DA1-40B3-AF2D-382CF6EB162AQ36370165-F58E7788-21D4-49B8-9EA8-E3638AA5BDB0Q36661876-62623953-B032-4317-93D7-4ADAF16E6E1DQ36842944-26A7F878-3F9C-45AB-B9B5-E99A1FE0A632Q36862120-4BF40250-F929-4FF9-82CC-25CEC5637EE3Q36907090-AB04D34C-93B4-4274-B85F-3BB2F468900FQ37474532-721BCB64-ECB4-4BFE-AE69-D469835ECE49Q37563857-1FE751F6-E399-4419-B440-4D9D3E379F97Q37606205-F3AE157E-C7C4-43E3-8196-85A03FD95E86Q37611647-6BBCF412-39D8-47BF-9565-BA19AB62DE08Q37638268-FC75E8FB-3457-4D6A-A706-D23CF8F38B5FQ37739695-259A3473-997A-45EA-9AF9-31B0C0DDBF2E
P2860
Defective histone acetylation is responsible for the diminished expression of cyclooxygenase 2 in idiopathic pulmonary fibrosis.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Defective histone acetylation ...... idiopathic pulmonary fibrosis.
@en
Defective histone acetylation ...... idiopathic pulmonary fibrosis.
@nl
type
label
Defective histone acetylation ...... idiopathic pulmonary fibrosis.
@en
Defective histone acetylation ...... idiopathic pulmonary fibrosis.
@nl
prefLabel
Defective histone acetylation ...... idiopathic pulmonary fibrosis.
@en
Defective histone acetylation ...... idiopathic pulmonary fibrosis.
@nl
P2093
P2860
P356
P1476
Defective histone acetylation ...... idiopathic pulmonary fibrosis.
@en
P2093
Carol A Feghali-Bostwick
Keiria Watts
Linhua Pang
William R Coward
P2860
P304
P356
10.1128/MCB.01776-08
P407
P50
P577
2009-06-01T00:00:00Z